on 'Contract Manufacturing'

1-20 of 156 < first | prev | | last >
  • How to find the right CDMO partner in pharma

    Taking into account the hundreds of pharmaceutical CDMOs out there to choose from, picking the right CDMO can quickly become a daunting task. The good news is there are a couple of deciding factors that remain constant industry wide.

    Judy Meyers, Senior Business Development Manager, Grand River Aseptic Manufacturing
  • Changing Cupid's Contract

    Pharma CMOs are sharpening their arrows and getting noticed

    Karen Langhauser, Chief Content Director
  • Sustainable Drugs From the Start

    China-based Porton Pharma’s partnership with Codexis will bring new and improved manufacturing routes for APIs

    Karen Langhauser, Chief Content Director
  • CMOs on Fire

    Four contract manufacturers who are redefining what it means to outsource

  • Build Biologics Not Barriers

    iBio’s unique partnership with Beijing’s CC-Pharming will bring economical, plant-derived rituximab to China

    Karen Langhauser, Chief Content Director
  • Rethinking Isolation

    Berkshire Sterile Manufacturing’s souped-up isolator system offers a first-of-its-kind process for sterile manufacturing

    Meagan Parrish, Senior Editor
  • China's Biopharma Growth: Can it Continue?

    A new study shows a projected doubling of sales volume by 2021, as China strives to catch up with the global market

    Vicky (Qing) Xia, Senior Project Director, BioPlan Associates
  • Many Knives in the Air

    Contract manufacturers use their talents to juggle the risks of multi-product manufacturing

    Karen Langhauser, Chief Content Director
  • Cutting-Edge Flexibility

    CDMOs perfect the art of survival in today’s multi-product world

    Karen Langhauser, Chief Content Director
  • EU FMD: The One-Year Countdown

    Companies that manufacture, sell or dispense drugs in the European Union have until February 9, 2019 to comply. Where does the industry stand?

    Pharmaceutical Manufacturing staff
  • The Evolving Biopharma Contract-Manufacturing Market

    Once biopharma companies optimize operations in order to free up hidden capacity, they have four options: build, acquire, partner or face the realities of outsourcing

    Andrea Gennari, Martin Loesch, Alberto Santagostino and Ralf Otto, McKinsey & Co.
  • Inking the Deal

    Mastering the art of lasting outsourcing relationships in the pharmaceutical industry

    Karen Langhauser, Chief Content Director
1-20 of 156 < first | prev | | last >